Use of its orsaline suspended
The International Centre for Diarrhoeal Diseases Research, Bangladesh (icddr,b) has decided to stop using glucose and rice-based orsaline obtained from the icddr,b Employees' Multipurpose Cooperative Society.
The decision has been taken, as the cooperative's registration is pending with the Directorate General of Drug Administration, which regulates oral saline under the Drug Act of 1982, according to a statement of icddr, b yesterday.
“We have no concerns about the quality of the oral saline produced by the cooperative, but we have contracted an alternative supplier until this matter is resolved,” said Prof John D Clemens, executive director of icddr,b.
Patient care at icddr,b hospitals in Dhaka and Matlab of Chandpur will not be interrupted during this transition, said the statement.
Recently, a mobile court of Rapid Action Battalion sealed off an illegal factory in the capital that produced fake oral saline and marketed those in the name of icddr,b.
Following the incident, it was found that the cooperative society was not registered with the DGDA.
Orsaline was developed by icddr,b in the late 1960's, and since then, is estimated to have saved at least 50 million lives worldwide.
Comments